Use of povidone-iodine in periodontal practice – advantages and limitations of action

Jan Kowalski

Streszczenie

Skuteczna eliminacja biofilmu bakteryjnego jest kluczowa w uzyskaniu powodzenia leczenia periodontologicznego. Jodopowidon (PVP-I) jest możliwym do przewlekłego stosowania środkiem przeciwbakteryjnym, mającym stosunkowo niewiele przeciwwskazań , i może stanowić cenną alternatywę lub wsparcie dla  obecnie stosowanych antyseptyków do higieny jamy ustnej.

 

Abstract

Effective elimination of bacterial biofilm is a key factor for the attainment of success in periodontal treatment. Povidone-iodine (PVP-I) is a possibility as a source for chronic treatment used as an antibacterial agent having relatively few contraindications and may be a valuable alternative or support for currently used antiseptics for oral hygiene.

 

Hasła indeksowe: biofilm bakteryjny, sukces leczenia periodontologicznego, powidonek jodyny

 

Key words: bacterial biofilm, success in periodontal treatment, povidone-iodine

PIŚMIENNICTWO

1. Higashitsutsumi M. i wsp.: Bactericidal effects of povidone-iodine solution to oral pathogenic bacteria in vitro. Postgrad. Med. J., 1993, 69,  Suppl. 3, S10-14.

2. Hosaka Y. i wsp.: Antibacterial activity of povidone-iodine against an artificial biofilm of Porphyromonas gingivalis and Fusobacterium nucleatum. Arch. Oral Biol., 2012, 57, 364-368.

3. Shiraishi T., Nakagawa Y.: Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations. Dermatology, 2002, 204, Suppl. 1:, 37-41.

4. Domingo M.A. i wsp.: The effect of 1% povidone iodine as a pre-procedural mouthrinse in 20 patients with varying degrees of oral hygiene. J. Philipp. Dent. Assoc., 1996, 48, 31-38.

5. Montevecchi M. i wsp.: Comparison of the antibacterial activity of an ozonated oil with chlorhexidine digluconate and povidone-iodine. A disk diffusion test. New Microbiol 2013;36:289-302.

6. Kunisada T. i wsp.: Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology, 1997, 195, Suppl. 2,14-18.

7.  Kawana R. i wsp.: Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology,1997,195, Suppl. 2, 29-35.

8.  Ito H. i wsp.:  Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Dermatology, 2006, 212,  Suppl. 1, 115-118.

9. Kariwa H., Fujii N., Takashima I.: Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. Jpn. J. Vet. Res., 2004, 52, 105-112.

10. Rosling B. i wsp.: The use of PVP-iodine as an adjunct to non-surgical treatment of chronic periodontitis. J. Clin. Periodontol.,  2001, 28, 1023-1031.

11. Forabosco A. i wsp.:  A comparative study of a surgical method and scaling and root planing using the Odontoson. J. Clin. Periodontol.,  1996, 23, 611-614.

12. Hoang T. i wsp.: Povidone-iodine as a periodontal pocket disinfectant. J Periodontal Res 2003;38:311-317.

13. Koshy G. i wsp.: Effects of single-visit full-mouth ultrasonic debridement versus quadrant-wise ultrasonic debridement. J Clin Periodontol., 2005, 32, 734-743.

14. Leonhardt A. i wsp.: Microbiological effect of the use of an ultrasonic device and iodine irrigation in patients with severe chronic periodontal disease: a randomized controlled clinical study. Acta Odontol. Scand., 2007, 65, 52-59.

15. Sahrmann P. i wsp.: Systematic review on the effect of rinsing with povidone-iodine during nonsurgical periodontal therapy. J. Periodontal Res., 2010, 45, 153-164.

16. Sahrmann P. i wsp.: Clearance of topically-applied PVP-iodine as a solution or gel in periodontal pockets in men. Acta Odontol. Scand., 2012, 70, 497-503.

17. Sahrmann P. i wsp.: Povidone-iodine gel and solution as adjunct to ultrasonic debridement in nonsurgical periodontitis treatment: an RCT pilot study. Quintessence Int., 2014, 45, 281-290.

18. Dajani A.S. i wsp.: Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin. Infect. Dis., 1997, 25, 1448-1458.

19. Rahn R. i wsp. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology, 1997, 195 Suppl. 2, 57-61.

20.  Grossi S.G. i wsp.: Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J. Periodontol., 1997, 68, 713-719.

21.  Kramer S.A.: Effect of povidone-iodine on wound healing: a review. J. Vasc. Nurs., 1999, 17, 17-23.

22. Burks R.: Povidone-iodine solution in wound treatment. Phys. Ther., 1998, 78, 212-218.

23. Fumal I. i wsp.: The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study. Dermatology, 2002, 204,  Suppl. 1, 70-74.

24. Niedner R.: Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology, 1997, 195,  Suppl. 2, 89-92.

25. Reyazulla M.A. i wsp.: An unusual complication of late onset allergic contact dermatitis to povidone iodine in oral & maxillofacial surgery –  a report of 2 cases. Eur. Ann. Allergy Clin. Immunol., 2014, 46,157-159.

26. Amin M.S. i wsp.: Effect of povidone-iodine on Streptococcus mutans in children with extensive dental caries. Pediatr. Dent., 2004, 26, 5-10.

27. Ader A.W. i wsp.: Effect of mouth rinsing with two polyvinylpyrrolidone-iodine mixtures on iodine absorption and thyroid function. J. Clin. Endocrinol. Metab., 1988, 66, 632-635.